Disc Medicine, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Disc Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Disc Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$26.6M, a 88.4% decline year-over-year.
  • Disc Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$103M, a 61.4% decline year-over-year.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$76.4M, a 63.2% decline from 2022.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.8M, a 30.2% decline from 2021.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$36M, a 11.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$103M -$26.6M -$12.5M -88.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$91M -$26.4M -$10.4M -65.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$80.6M -$26.9M -$4.17M -18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$76.4M -$23.6M -$12.3M -110% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$64.1M -$14.1M +$2.03M +12.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$66.1M -$15.9M -$6.37M -66.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$59.8M -$22.8M -$12.9M -131% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$46.8M -$11.2M -$29.3M -162% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$17.5M -$16.2M +$2.4M +12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$19.9M -$9.58M +$6.87M +41.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$26.8M -$9.85M +$9.2M +48.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$36M $18.1M +$32.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$68.4M -$18.6M -$8.55M -85.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$59.8M -$16.4M -$9.67M -143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$50.1M -$19M -$9.3M -95.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$40.8M -$14.3M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$10M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$6.77M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$9.75M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.